NephroQuiz: muscles and bananas.

NephroQuiz is curated by BMC Nephrology Editorial Board Members from Johns Hopkins University, Dr. Hanouneh and Dr. Cervantes. It aims to engage readers with clinical vignettes and problem solving. The USMLE-style questions are designed to test knowledge and engage with published literature.
NephroQuiz: muscles and bananas.
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

A 40-year-old African American man arrived at the emergency room experiencing profound muscle weakness. Past medical history revealed sporadic muscle tightness occurring 1-3 times per week, alleviated by consuming bananas. He was not using any medications, and his family history was noteworthy for hyperthyroidism and episodes of hypokalemia in his brother and mother.

Upon presentation, vital signs were temperature 98.4°F, blood pressure 127/83 mmHg, heart rate 111 beats/minute, respiratory rate 11 breaths/ minute, and oxygen saturation 96% on room air. Physical examination revealed pronounced weakness in both upper and lower extremities (strength assessed at 0/5) with areflexia.

Laboratory results are shown in Table 1. The electrocardiogram demonstrated sinus tachycardia with prolonged QTc interval of 606 ms. Swift replacement of hypokalemia effectively alleviated his symptoms, albeit leading to transient hyperkalemia that spontaneously resolved.

 Table 1. Basic Laboratory Tests. 

Tests​

Results​

Normal range​

Sodium​

139 mmol/L​

132-148 mmol/L​

Potassium

<1.5 mmol/L

3.5-5 mmol/L​

Chloride​

105 mmol/L​

98-111 mmol/L​

Bicarbonate​

21 mmol/L​

23-32 mmol/L​

Blood Urea Nitrogen​

18 mg/dL​

10-25 mg/dL​

Creatinine​

0.91 mg/dL​

0.7-1.4 mg/dL​

Calcium ​

9.3 mg/dL​

8.4-10.5 mg/dL​

Albumin​

3.9 g/dL​

3.5-5.0 g/dL​

Total protein​

7.2 g/dL ​

6.6-8.7 g/dL​

Glucose​

90 mg/dL​

65-100 mg/dL​

Magnesium 

1.9 mg/dL

1.6-2.6 mg/dL​

Phosphorus ​

2.1 mg/dL

2.5-4.5 mg/dL ​

AST​

64 U/L​

5-40 U/L​

ALT​

153 U/L​

5-41​

Bilirubin- total ​

0.3 mg/dL ​

0.2-1.2 mg/dL​

Alkaline phosphatase ​

79 U/L​

40-129 U/L​

Random urine K/Cr ratio​

10.7 mmol/g Cr

17-121 mmol/g Cr​

TSH

< 0.006 mcIU/mL

0.270-4.200 mcIU/mL​

Free T3

13.0 pg/mL

2.1-4.4 pg/mL​

Free T4 

3.04 ng/dL

0.9-1.70 ng/dL​

Thyroid Stimulating Ig (TSI)

3.43 IU/L

<=0.54 IU/L​

Thyroid Peroxidase Ab 

62.6 IU/mL

0.0-9.0 IU/mL​

The correct answer, link to published case and explanation will be provided in the comment section. 

Click here to read the original case report, published in BMC Nephrology. We encourage discussion of the case and questions in the comments. 

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Go to the profile of Mikhail Sinelnikov
29 days ago

The correct answer is explained below:

.

.

.

.

.

The correct answer is: hypokalemic periodic paralysis. 

Periodic paralysis (PP) is a rare channelopathy marked by recurrent episodes of flaccid skeletal muscle paralysis. Hypokalemic periodic paralysis (HypoPP) is categorized into familial or acquired forms. Triggers for episodes of HypoPP are primarily associated with intense exercise and high carbohydrate intake, and less frequently related to viral infections, stress, cold, salt consumption, and medications (such as glucocorticoids and insulin). 

Familial HypoPP is associated with variants in the skeletal muscle sodium channel gene SCN4A in 20% of patients or the L-type calcium channel gene CACNA1S in 60% of patients. The majority of reported pathogenic variants involve arginine residues in S4 transmembrane segments, with notable hotspots at codons R528 and R1239. Generally, the existence of hyperthyroidism is more strongly associated with a diagnosis of acquired thyrotoxic periodic paralysis (TPP), with most cases occurring in Asian males without a family history of the condition. Pathogenic variants in KCNJ2 and KCNJ18 are associated with susceptibility to TPP.  KCNJ2 and KCNJ18 encode Kir 2.1 and Kir2.6 respectively, inwardly rectifying potassium channels expressed in skeletal muscle and transcriptionally regulated by thyroid hormone.

Genetic testing in the discussed patient revealed a heterozygous pathogenic variant in CACNA1S [c.1583 G>A (p. R528H)] and normal sequencing of SCN4A, KCNJ2 and KCNJ18. The patient received a diagnosis of familial hypokalemic periodic paralysis and concurrent hyperthyroidism due to Graves’ disease. The likelihood of TPP in this case is reduced, given the patient is not of Asian descent, has a family history of HypoPP, and lacks identifiable variants in KCNJ2 and KCNJ18. The pathogenic variant observed in this case has been documented previously. This variant leads to a substantial reduction in the whole-cell calcium channel current and induces depolarization of the resting cell potential in response to hypokalemia.

Management of acute paralytic episodes involves maintaining proper control of serum potassium levels, necessitating vigilant monitoring for post-treatment hyperkalemia. Lifestyle and dietary modifications to avoid triggering factors are integral to treatment. Although the precise mechanism is not fully elucidated, carbonic anhydrase inhibitors have demonstrated efficacy in reducing the frequency of familiar HypoPP episodes. There is variability in the response to carbonic anhydrase inhibitors based on genotype; individuals with CACNA1S variants tend to exhibit a more favorable response compared to SCN4A variants. Additionally, the incorporation of a potassium-sparing diuretic, either in conjunction with carbonic anhydrase inhibitors or as a standalone treatment, may offer advantages for specific patients.

Read more in the published article: https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-024-03749-x

Follow the Topic

Nephrology
Life Sciences > Health Sciences > Clinical Medicine > Nephrology
Clinical Medicine
Life Sciences > Health Sciences > Clinical Medicine
Nutrition
Life Sciences > Health Sciences > Health Care > Nutrition
Medical Genetics
Life Sciences > Biological Sciences > Genetics and Genomics > Medical Genetics
  • BMC Nephrology BMC Nephrology

    This is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of kidney and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.

Related Collections

With collections, you can get published faster and increase your visibility.

Immune system regulation in the kidneys

BMC Nephrology invites submissions to our Collection on Immune system regulation in the kidneys. Immune system regulation can play an important role in kidney function, with intricate mechanisms governing the interaction between the renal system and immune cells. Understanding the modulation and regulation of the immune system within the kidneys is essential for comprehending the pathophysiology of renal inflammation and immune-mediated kidney diseases. Research in this area encompasses the study of immune cell populations, immunosuppressive functions, and the maintenance of immune homeostasis within the renal microenvironment. Advancing our collective understanding of immune system regulation in the kidneys is vital for identifying the underlying mechanisms of renal inflammation and immune-mediated kidney diseases. Recent advances have revealed the pivotal role of regulatory immune cells in maintaining immune homeostasis and preventing excessive immune activation within the kidneys. Furthermore, studies have highlighted the complex interplay between immune cells and renal cells, shedding light on the mechanisms of immune-mediated kidney injury and potential targets for therapeutic intervention. Looking ahead, continued research in this area holds the potential for uncovering novel immunomodulatory pathways and therapeutic targets for immune-mediated kidney diseases. Future advances may include the development of targeted immunotherapies aimed at restoring immune homeostasis within the inflamed kidney microenvironment, as well as the identification of biomarkers for early detection and monitoring of immune-mediated kidney diseases. Topics of interest include, but are not limited to: - Immune cell populations in the kidneys - Immunomodulatory mechanisms in renal inflammation - Regulatory T cells and immune homeostasis in the kidneys - Immune-mediated kidney diseases - Role of dendritic cells in renal immune regulation - The impact of gut microbiota on renal immune responses - Novel immunotherapies for immune-mediated kidney diseases - Crosstalk between innate and adaptive immune cells in renal inflammation - The influence of aging on immune regulation in the kidneys This Collection supports and amplifies research related to SDG 3: Good Health and Wellbeing.

Publishing Model: Open Access

Deadline: Mar 17, 2025

Advances in acute kidney injury

For this Collection, BMC Nephrology is looking for contributions that discuss the latest insights, innovations, and technological advancements, with a focus on biomarkers for early detection, public awareness and policy implications, innovative therapeutic approaches, renal replacement therapy, and risk factors and prevention strategies.

Publishing Model: Open Access

Deadline: Jan 03, 2025